RTI Surgical

Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. Its products portfolio include cervical fixation, The Streamline (TL) fixation, motion preservation, orthobiologics, cervical inter-body fusion, TL IBF, and SI joint fusion. It offers coflex interlaminar stabilization device, SImmetry sacroiliac joint fusion system, and Fortilink IBF system with TETRAfuse?3D technology. The company was founded on February 12, 1998 and is headquartered in Deerfield, IL.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

RTI Surgical - OEM Business designs, develops, manufactures and distributes biologic, metal and synthetic implants for a global customer base. Its implants are used in a variety of surgical procedures including orthopaedic, spine, sports medicine, general surgery and trauma.

MARQUETTE, Mich., Sept. 22, 2020 /PRNewswire/ -- RTI Surgical recently received 510(k) Clearance from the U.S. Food and Drug Administration (FDA) for the Dynamic Active Compression (DAC) Plate to provide stabilization and fixation of small bones of the foot. The DAC plate addresses an...

RTI Surgical® Receives 510(k) Clearance for Dynamic Active Compression (DAC) Plate

DEERFIELD, Ill., July  20, 2020  (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (formerly RTI Surgical Holdings, Inc.) (Nasdaq: RTIX), a global surgical implant company, today announced the closing of the sale of the OEM business, effective July 20, 2020, for a total consideration of $440 million, paid in cash.

Surgalign Holdings, Inc. (formerly RTI Surgical Holdings, Inc.

ALACHUA, Fla.--(BUSINESS WIRE)--Today, Montagu Private Equity LLP, announced the completion of its acquisition of the RTI Surgical OEM business.

Montagu Private Equity LLP Completes Acquisition of the RTI Surgical OEM Business

DEERFIELD, Ill., July  15, 2020  (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced that following the Company’s annual stockholder meeting, which included an annual meeting of the stockholders, the Company has received all of the necessary approvals for the sale of the OEM business. The Company expects the transaction to close on Monday, July 20, 2020.

RTI Surgical Announces Stockholder Approval for Sale of OEM Business, Planned Name and Ticker Change, and Leadership Transitions

DEERFIELD, Ill., July  02, 2020  (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced that, due to the public health impact of the coronavirus outbreak (COVID-19), its Annual Meeting of Stockholders, to be held on Wednesday, July 15, 2020 at 9:00 a.m. Central Daylight Time (the “Annual Meeting”), has been changed to a virtual-only meeting. Stockholders will not be able to attend the Annual Meeting in person this year. Stockholders are entitled to participate in the Annual Meeting if they were a stockholder as of the close of business on June 4, 2020, the record date, or hold a legal proxy for the meeting provided by the stockholder’s bank, broker, or nominee.

RTI Surgical Holdings, Inc.® to Hold Virtual-Only Annual Meeting of Stockholders

Surgical implants comprise a growing market, and investors can participate in this trend through a position in RTIX stock.
The post Commit to a High-Need Medical Niche with RTIX Stock appeared first on InvestorPlace.

Commit to a High-Need Medical Niche with RTIX Stock

RTI Surgical Holdings, Inc. (RTIX) CEO Camille Farhat on Q1 2020 Results - Earnings Call Transcript

DEERFIELD, Ill., June  30, 2020  (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, today provided a business update in conjunction with releasing financial and operating results for the quarter ended March 31, 2020.

RTI Surgical Holdings, Inc.® Provides Business Updates

RTIX currently operates two distinct businesses: an OEM tissue and a spinal implant business.

Historically Discounted RTI Surgical Transitioning To Pure Play Spine Competitor With Significant Upside

DEERFIELD, Ill., June  24, 2020  (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced it plans to hold a business update call, and in conjunction release financial and operating results for the quarter ended March 31, 2020, on Tuesday, June 30, 2020, prior to the market open.

RTI Surgical Holdings, Inc.® Schedules Business Update Call for June 30, 2020

Agenus

Amyris

Inspired Entertainment

OpGen

If you’re looking for some hedges for your portfolio or are looking to shift against the market, our deep learning algorithms and AI technology have several Top Shorts for you today.

Top Stocks To Short During Current Market Sell Off

Scott Durall Appointed as Chief Commercial Officer   Bryan Cornwall Appointed as Executive Vice President, Research and Clinical Affairs

RTI Surgical Holdings, Inc.® Bolsters Spine Business with Key Senior Leadership Appointments

DEERFIELD, Ill., June  08, 2020  (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced that it has completed the filing of its 2019 Form 10-K and has completed its previously announced financial statement restatement.

RTI Surgical Holdings, Inc.® Announces Filing of 2019 10-K and Completion of Financial Statement Restatement

DEERFIELD, Ill., May  26, 2020  (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced the appointment of Stuart F. Simpson as an independent member of its board of directors.

RTI Surgical Holdings, Inc.® Appoints Stuart F.

NEW YORK, May 22, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of RTI Surgical Holdings, Inc. (NASDAQ: RTIX) between March 7, 2016 and March 16, 2020, inclusive (the "Class Period"), of the important May 22, 2020 lead...

RTIX FINAL DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Reminds RTI Surgical Holdings, Inc. Investors of Important May 22 Deadline in Securities Class Action - RTIX

NEW YORK, May 20, 2020 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in RTI Surgical Holdings, Inc. ("RTI" or the "Company") (NASDAQ:RTIX) of the May 22, 2020 deadline to seek the role of lead plaintiff in a federal securities class action...

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In RTI Surgical Holdings, Inc. To Contact The Firm

Restructured terms extend the outside date for closing to August 31, 2020 in exchange for a purchase price reduction and certain other modifications Restructured terms extend the outside date for closing to August 31, 2020 in exchange for a purchase price reduction and certain other modifications

RTI Surgical Holdings, Inc.® Announces Second Amendment to Equity Purchase Agreement

DEERFIELD, Ill., March  20, 2020  (GLOBE NEWSWIRE) -- As announced on March 16, 2020, RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, filed a Notification of Late Filing on Form 12b-25, indicating that the filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2019 (the “Form 10-K”) would be delayed pending completion of an internal investigation of current and prior periods relating to the Company’s revenue recognition practices involving the timing of revenue recognition with respect to certain contractual arrangements, primarily with OEM customers, including the accounting treatment, financial reporting and internal controls related to such arrangements.

RTI Surgical Holdings, Inc.® Receives Notification from Nasdaq Related to Delayed Annual Report on Form 10-K

DEERFIELD, Ill., March  16, 2020  (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, announced it will file a Form 12b-25 Notification of Late Filing with the Securities and Exchange Commission (the “SEC”) to provide a 15 calendar day extension within which to file its Form 10-K for the fiscal year ended December 31, 2019.

RTI Surgical Holdings, Inc.® to Delay Form 10-K filing for Fiscal Year 2019

DEERFIELD, Ill., March  03, 2020  (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvement Act of 1976, as amended (the “HSR Act”), with respect to the proposed sale (the “Sale”) of RTI’s OEM business to Ardi Bidco Ltd., a Delaware corporation and an entity affiliated with Montagu Private Equity, LLP (the “Buyer”), expired at 11:59 p.m. Eastern Time on February 28, 2020.

RTI Surgical Holdings, Inc.® Announces Expiration of Hart-Scott-Rodino Waiting Period With Respect to Sale of OEM Business

Interim results in the EVoluSIon Study on the SImmetry® System further show 78 percent of patients are opioid-free at 24 months Interim results in the EVoluSIon Study on the SImmetry® System further show 78 percent of patients are opioid-free at 24 months

RTI Surgical® Releases Data on the SImmetry® System Showing 98% of Treated SI Joints Demonstrate Evidence of Fusion

DEERFIELD, Ill., Feb.  25, 2020  (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, announced today that it has postponed the special meeting of its shareholders, which was scheduled for March 31, 2020 (the “Special Meeting”) to, among other things, consider and vote on various proposals necessary to close the previously announced Equity Purchase Agreement, dated January 13, 2020, with Ardi Bidco Ltd., a Delaware corporation and an entity affiliated with Montagu Private Equity, LLP (the “Buyer”), pursuant to which the Buyer will acquire the OEM business of the Company by means of a sale (the “Sale”) of certain affiliates of the Company. 

RTI Surgical Holdings, Inc.® Announces Postponement of Record Date and Stockholder Meeting Date for Sale of OEM Business

DEERFIELD, Ill., Jan.  28, 2020  (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, announced today that it has set the record date for the special meeting of its shareholders to, among other things, consider and vote on various proposals necessary to close the previously announced Equity Purchase Agreement, dated January 13, 2020 (the “Purchase Agreement”), with Ardi Bidco Ltd., a Delaware corporation and an entity affiliated with Montagu Private Equity, LLP (the “Buyer”), pursuant to which the Buyer will acquire the OEM business (the “Business”) of the Company by means of a sale (the “Sale”) of certain affiliates of the Company.

RTI Surgical Holdings, Inc.® Announces Record Date and Stockholder Meeting Date for Sale of OEM Business

RTI Surgical: Focus On Spine Performance

Compugen

Glu Mobile

GameStop

Groupon

Interpace Diagnostics

Meet Group

OrganiGram Holdings Inc.

Synlogic

Zynga

With stocks at all time highs and after the Dow rose more than 22% and the S&P 500 rose over 28% in 2019, many investors have yet to make many changes in the portfolios for what could be another solid 2020.

News for RTI Surgical Stock (RTIX)